Researcher
Catherine Verfaillie
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Stem Cell and Developmental Biology (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Infrastructure
1 - 1 of 1
- Platform for Next Generation Screening in Quantitative Biology & Drug Discovery (Consortium coordinator)
Projects
21 - 30 of 95
- Replacement and upgrade of electronics and gradients for preclinical magnetic resonance imagingFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
- MemoriesFrom1 Jan 2018 → 31 Dec 2020Funding: Other EU initiatives out of framework
- Human Stem Cell Derived Liver Cells for Disease Modeling and Whole Organ EngineeringFrom1 Jan 2018 → 20 Sep 2022Funding: BOF - doctoral mandates
- IPSC-HEPs: hepatotoxicity and drug metabolism by biotech and pharmaceutical companies.From1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- 3D multicellular culture systems for real time insights in physical and chemical signals underlying stem cell morphogenesis and lineage fateAcronym: 3DMuSyCFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption
- Research project ALS_OLFrom1 Sep 2017 → 31 Aug 2019Funding: Foreign private sponsor - undefined
- Elucidating the role of mutated fuced in sacroma (FUS) oligodenrocytes in the pathophysiology of amyotrophic lateral sclerosis using induced pluripotent stem cells.From1 Sep 2017 → 31 Dec 2021Funding: FWO fellowships
- Understanding the role of Base Excision Repair mechanisms in fetal liver and bone marrow hematopoietic stem cells.From19 Apr 2017 → 27 Sep 2023Funding: FWO fellowships
- Unraveling the role of TREM2 mutations in Alzheimer's disease using human Pluripotent Stem CellsFrom1 Jan 2017 → 31 Dec 2019Funding: Other federal public and semi-governmental institutions
- Mechanisms underlying increased tolerance of oxidative phosphorylation by fetal liver compared with bone marrow derived hematopoietic stem cellsFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 375
- Xenografted human microglia display diverse transcriptomic states in response to Alzheimer's disease-related amyloid-β pathology.(2024)
Authors: Sriram Balusu, Catherine Verfaillie, Bart De Strooper
- Glycolytic state of aortic endothelium favors hematopoietic transition during the emergence of definitive hematopoiesis.(2024)
Authors: Catherine Verfaillie
Pages: eadh8478 - Spatially Self-Organized Three-Dimensional Neural Concentroid as a Novel Reductionist Humanized Model to Study Neurovascular Development(2024)
Authors: Yoke Chin Chai, San Kit To, Yingli Zhu, Ben van der Veer, Vincent Pasque, Catherine Verfaillie
- Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF-κВ and WNT Signaling(2024)
Authors: Jonathan Chui, Aneta Malesa, Paraskevi ATHANASOULI, Joris Vriens, Kian Koh, Catherine Verfaillie, Frederic Lluis Vinas
- Robotics-Driven Manufacturing of Cartilaginous Microtissues for Skeletal Tissue Engineering Applications(2024)
Authors: Isaak Decoene, Gabriele Nasello, Catherine Verfaillie, Liesbet Geris, Frank Luyten, Ioannis Papantoniou
Pages: 278 - 292 - Automated Generation of hiPSC-Derived Hepatic Progeny by Cost-Efficient Compounds(2023)
Authors: Kristof De Vos, Teresa Izuel Idoype, Pieter Annaert, Frederic Lluis Vinas, Catherine Verfaillie
Pages: 1076 - 1088 - Editorial: New insights of immune cells in cardiovascular and metabolic disorders(2023)
Authors: Catherine Verfaillie
- Engineering Neurovascular Organoids and Morphogen Gradients with 3D Printed Microfluidic Chips(2023)
Authors: Idris Salmon, Adrian Ranga, Catherine Verfaillie
- APEX1 Nuclease and Redox Functions are Both Essential for Adult Mouse Hematopoietic Stem and Progenitor Cells(2023)
Authors: Samantha Zaunz, Lukas Lauwereins, Kim De Keersmaecker, Catherine Verfaillie
Pages: 2052 - 2072 - From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions(2023)
Authors: Catherine Verfaillie
Pages: 283 - 299
Patents
1 - 10 of 10
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Hydrogels for cell culture (Inventor)
- Nek6 inhibition to treat als and ftd (Inventor)
- Spheroidal self-assembled peptide hydrogels comprising cells (Inventor)
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Cell culture media for differentiation of stem cells into hepatocytes (Inventor)
- Methods for identifying activators and suppressors (Inventor)
- Stem cell aggregates and methods for making and using (Inventor)
- Cell therapy for myelodysplastic syndromes (Inventor)
- Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells (Inventor)